Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
Contacts
Capabilities
Suggested News & Insights
EU Pharma Package: Sharp New Tools With Limited ProtectionsDecember 19, 2025EU Pharma Package: Sharp New Tools With Limited ProtectionsDecember 18, 2025EU Biotech Act: EU Proposes First Set of Rules to Facilitate Biopharmaceutical CompetitivenessThursday, December 18, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

